Introduction Part D:
Introduction Summary

  1. While AIDS has been a serious health problem from its first appearance a quarter of a century ago, it has been strategically developed into a global health epidemic by the very interest group that pretends to fight it – namely the pharmaceutical investment business.
  2. The pharmaceutical multinationals promote the AIDS epidemic particularly in the developing world for two main reasons: First, they depend on the continuation and expansion of this disease as a multibillion Rand marketplace for their patented ARVs. Secondly, by forcing the governments of the developing world to spend an ever increasing amount of their national budgets to be paid to pharmaceutical multinationals – thereby cementing economic dependency of the poor nations from the rich.

Pharmaceutical Colonialism And Its Consequences For Developing Countries

  1. Pharmaceutical colonialism is the expansion of the pharmaceutical investment business with disease to the developing world. The market of pharmaceutical colonialism is the human body of billions of people living in the developing world and the diseases it harbours. These diseases are the marketplace for a multi-billion Rand business with patented drugs.
  2. This marketplace of pharmaceutical colonialism in the developing world is particularly growing rapidly, because the health of the people in these countries is already severely compromised by malnutrition, poverty and other relics of the colonialism of earlier centuries. These preconditions are being strategically used by the pharmaceutical investment business to conquer and expand these markets for their patented drugs.
  3. Since the people in the developing world are – as a result of previous forms of colonialism – generally poor and unable to pay for the patented drug merchandise, the stakeholders of pharmaceutical colonialism developed strategies to force the governments of the developing nations to use its revenues to provide for the “return on investment” for this industry.
  4. Towards this end, pharmaceutical colonialism – through its stakeholders inside and outside the country – continuously increases the pressure on the governments of these developing nations and coerces them to pay their “tributes” to the pharmaceutical investment business. In order to enforce these tribute payments, pharmaceutical colonialism establishes specific “pressure groups” inside these countries that – under the pretext of fighting for “health rights” – use defamation, intimidation, coercion and even violence to reach its goals.
  5. Pharmaceutical colonialism in the developing world today has strategically replaced the colonialism of earlier centuries. This form of colonialism no longer knows any national boundaries, and the colonial armies have been replaced by the power of international financial trusts.
  6. The “tribute” payments to the pharmaceutical investment business from the developing world – compelled by the instruments of pharmaceutical colonialism – are financing the global reign of one of the most profitable and most unscrupulous investment businesses ever, with annual revenues surpassing the gross national product of the 100 poorest nations of the world.